Medtronic plc (MDT)
Medtronic (MDT) Laps the Stock Market: Here's Why
The latest trading day saw Medtronic (MDT) settling at $86.68, representing a +1.51% change from its previous close.
Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It
Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know
Medtronic (MDT) closed at $84.22 in the latest trading session, marking a +1.21% move from the prior day.
Orchestra BioMed: Nearing The First Of Two Pivotal Readouts
Orchestra BioMed is approaching pivotal trial readouts for AVIM Therapy and Virtue SAB, both with strong success potential. OBIO operates as an innovation and clinical development platform for medical devices, relying on Medtronic and Terumo for commercialization. Medtronic and Terumo have invested a combined $146 million, with OBIO's $220 million valuation reflecting a modest premium to strategic funding and with significant potential upside as catalysts approach.
Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors
Medtronic (MDT) reached $82.35 at the closing of the latest trading day, reflecting a -1.13% change compared to its last close.
Medtronic (MDT) Exceeds Market Returns: Some Facts to Consider
Medtronic (MDT) reached $83.87 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.
Medtronic: Undervalued, And The Tailwinds Are Just Getting Started
I initiate coverage on Medtronic, highlighting its status as a leading medtech name with premium margins. MDT offers an attractive diversification opportunity, combining consistent performance with accelerated revenue growth. The stock trades at undervalued levels, supporting a long-term bullish thesis and a defensive investment approach.
Medtronic: A Near Decade High Dividend For This Aristocrat
Medtronic is a dividend aristocrat with a near-decade high yield, making it an attractive long-term income opportunity. The company is experiencing strong revenue growth, driven by its leading positions in cardiovascular and neuroscience medical devices. While current free cash flow payout ratios are sustainable, investors should monitor future dividend growth rates closely.
Why Is Medtronic (MDT) Up 1.5% Since Last Earnings Report?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know
Medtronic (MDT) reached $78.23 at the closing of the latest trading day, reflecting a -3.34% change compared to its last close.
Is It Worth Investing in Medtronic (MDT) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
This Undervalued Medical-Devices Stock Is Poised for a Rebound
Medtronic offers high growth potential in addition to discounted valuation.
